Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Intervalo de año de publicación
1.
Science ; 369(6508): 1255-1260, 2020 09 04.
Artículo en Inglés | MEDLINE | ID: mdl-32703910

RESUMEN

Brazil currently has one of the fastest-growing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemics in the world. Because of limited available data, assessments of the impact of nonpharmaceutical interventions (NPIs) on this virus spread remain challenging. Using a mobility-driven transmission model, we show that NPIs reduced the reproduction number from >3 to 1 to 1.6 in São Paulo and Rio de Janeiro. Sequencing of 427 new genomes and analysis of a geographically representative genomic dataset identified >100 international virus introductions in Brazil. We estimate that most (76%) of the Brazilian strains fell in three clades that were introduced from Europe between 22 February and 11 March 2020. During the early epidemic phase, we found that SARS-CoV-2 spread mostly locally and within state borders. After this period, despite sharp decreases in air travel, we estimated multiple exportations from large urban centers that coincided with a 25% increase in average traveled distances in national flights. This study sheds new light on the epidemic transmission and evolutionary trajectories of SARS-CoV-2 lineages in Brazil and provides evidence that current interventions remain insufficient to keep virus transmission under control in this country.


Asunto(s)
Betacoronavirus/genética , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/transmisión , Neumonía Viral/epidemiología , Neumonía Viral/transmisión , Número Básico de Reproducción , Teorema de Bayes , Betacoronavirus/clasificación , Brasil/epidemiología , COVID-19 , Prueba de COVID-19 , Ciudades/epidemiología , Técnicas de Laboratorio Clínico , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/prevención & control , Infecciones por Coronavirus/virología , Europa (Continente) , Evolución Molecular , Genoma Viral , Humanos , Modelos Genéticos , Modelos Estadísticos , Pandemias/prevención & control , Filogenia , Filogeografía , Neumonía Viral/prevención & control , Neumonía Viral/virología , SARS-CoV-2 , Análisis Espacio-Temporal , Viaje , Población Urbana
2.
Mem Inst Oswaldo Cruz ; 109(5): 540-5, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25099334

RESUMEN

Plasmodium vivax is the most widespread parasite causing malaria, being especially prevalent in the Americas and Southeast Asia. Children are one of the most affected populations, especially in highly endemic areas. However, there are few studies evaluating the therapeutic response of infants with vivax malaria. This study retrospectively evaluated the parasitaemia clearance in children diagnosed with vivax malaria during the first five days of exclusive treatment with chloroquine (CQ). Infants aged less than six months old had a significantly slower parasitaemia clearance time compared to the group of infants and children between six months and 12 years old (Kaplan-Meier survival analysis; Wilcoxon test; p = 0.004). The impaired clearance of parasitaemia in younger children with vivax malaria is shown for the first time in Latin America. It is speculated that CQ pharmacokinetics in young children with vivax malaria is distinct, but this specific population may also allow the detection of CQ-resistant parasites during follow-up, due to the lack of previous immunity.


Asunto(s)
Antimaláricos/uso terapéutico , Cloroquina/uso terapéutico , Malaria Vivax/tratamiento farmacológico , Parasitemia/tratamiento farmacológico , Plasmodium vivax/efectos de los fármacos , Factores de Edad , Antimaláricos/efectos adversos , Brasil , Niño , Preescolar , Cloroquina/efectos adversos , Resistencia a Medicamentos , Femenino , Humanos , Lactante , Estimación de Kaplan-Meier , Malaria Vivax/parasitología , Masculino , Parasitemia/parasitología , Estudios Retrospectivos , Factores de Tiempo
3.
Mem. Inst. Oswaldo Cruz ; 109(5): 540-545, 19/08/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-720423

RESUMEN

Plasmodium vivax is the most widespread parasite causing malaria, being especially prevalent in the Americas and Southeast Asia. Children are one of the most affected populations, especially in highly endemic areas. However, there are few studies evaluating the therapeutic response of infants with vivax malaria. This study retrospectively evaluated the parasitaemia clearance in children diagnosed with vivax malaria during the first five days of exclusive treatment with chloroquine (CQ). Infants aged less than six months old had a significantly slower parasitaemia clearance time compared to the group of infants and children between six months and 12 years old (Kaplan-Meier survival analysis; Wilcoxon test; p = 0.004). The impaired clearance of parasitaemia in younger children with vivax malaria is shown for the first time in Latin America. It is speculated that CQ pharmacokinetics in young children with vivax malaria is distinct, but this specific population may also allow the detection of CQ-resistant parasites during follow-up, due to the lack of previous immunity. .


Asunto(s)
Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Antimaláricos/uso terapéutico , Cloroquina/uso terapéutico , Malaria Vivax/tratamiento farmacológico , Parasitemia/tratamiento farmacológico , Plasmodium vivax/efectos de los fármacos , Factores de Edad , Antimaláricos/efectos adversos , Brasil , Cloroquina/efectos adversos , Resistencia a Medicamentos , Estimación de Kaplan-Meier , Malaria Vivax/parasitología , Parasitemia/parasitología , Estudios Retrospectivos , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA